2,6-Dichlorobenzaldehyde oxime

Catalog No.: 
ACCMLR967
CAS No.: 
25185-95-9
Molecular Formula: 
C7H5Cl2NO
Molecular Weight: 
190.03
2,6-Dichlorobenzaldehyde oxime structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$71.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Dichlorobenzaldehyde oxime
IUPAC Name2,6-dichlorobenzaldehyde oxime
Molecular FormulaC7H5Cl2NO
Molecular Weight190.03
SMILESClC1=C(C(Cl)=CC=C1)C=NO
InChI KeyYBSXDWIAUZOFFV-UHFFFAOYSA-N
SynonymAKOS001094495 | A817687 | SCHEMBL533867 | CS-M0366 | N-[(2,6-dichlorophenyl)methylidene]hydroxylamine | (NE)-N-[(2,6-dichlorophenyl)methylidene]hydroxylamine | W-107254 | AS-80758 | (E)-1-(2,6-dichlorophenyl)-N-hydroxymethanimine | 2,6-Dichlorobenzaldehyd
CAS No.25185-95-9

Safety Data

Pictogram
ToxicFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H228-H301-H315-H319-H335-H372
Precautionary Statement(s)
P210-P240-P264-P270-P280-P301+P310-P330-P370+P378-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCMLR967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMLR967 route product structure diagram
    ACCMLR96725185-95-9In Stock
Inquiry

2. ACCMLR967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMLR967 route product structure diagram
    ACCMLR96725185-95-9In Stock
Inquiry

3. ACCMLR967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMLR967 route product structure diagram
    ACCMLR96725185-95-9In Stock
Inquiry

Comments (0)